BrightSpring Health Q1 2024 Adj EPS $0.12 Beats $0.07 Estimate, Sales $2.577B Beat $2.313B Estimate
BrightSpring Health Q1 2024 Adj EPS $0.12 Beats $0.07 Estimate, Sales $2.577B Beat $2.313B Estimate
BrightSpring Health 2024年第一季度调整后每股收益为0.12美元，超过预期的0.07美元，销售额为25.77亿美元，超过23.13亿美元的预期
BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.07 by 71.43 percent. This is a 220 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $2.577 billion which beat the analyst consensus estimate of $2.313 billion by 11.41 percent. This is a 27.07 percent increase over sales of $2.028 billion the same period last year.
BrightSpring Health（纳斯达克股票代码：BTSG）公布的季度收益为每股0.12美元，比分析师普遍预期的0.07美元高出71.43％。这比去年同期每股亏损0.10美元（0.10）增长了220％。该公司公布的季度销售额为25.77亿美元，比分析师共识估计的23.13亿美元高出11.41％。这比去年同期的20.28亿美元销售额增长了27.07％。